Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease

Markus Lassila; Kei Fukami; Karin Jandeleit‐Dahm; Timothy Semple; Peter Carmeliet; M. E. Cooper; A. Richard Kitching

doi:10.1007/s00125-007-0652-x

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Plasminogen Activator Inhibitor-1 Is a Significant Determinant of Renal Injury in Experimental Crescentic Glomerulonephritis

A. Richard Kitching, Yao Kong, Xiao Ru Huang, Piers Davenport, Kristy L. Edgtton, Peter Carmeliet, Stephen R. Holdsworth, Peter G. Tipping

Article2002

Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine Carotid Artery Ligation Model

Vivian de Waard, E. Karin Arkenbout, Peter Carmeliet, Volkhard Lindner, Hans Pannekoek

Article2003

Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumonia

Anita W. Rijneveld, Sandrine Florquin, Paul Bresser, Marcel Levi, Vivian de Waard, Roger Lijnen, Jaring S. van der Zee, Peter Speelman, Peter Carmeliet, Tom van der Poll

Article2006

Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia

Rosemarijn Renckens, Joris J. T. H. Roelofs, Peter I. Bonta, Sandrine Florquin, Carlie J.M. de Vries, Marcel Levi, Peter Carmeliet, Cornelis van’t Veer, Tom van der Poll

Article1999

Plasminogen Activator Inhibitor-1 Is a Major Determinant of Arterial Thrombolysis Resistance

Yanhong Zhu, Peter Carmeliet, William P. Fay